Immunome, Inc. · NASDAQ:IMNM

Vanguard Capital Management LLC reported a 5.04% stake in Immunome, Inc. (Schedule 13G)

Event Sep 30, 2026 · Filed Oct 30, 2026

Vanguard Capital Management LLC reported a 5.04% stake in Immunome, Inc., 5,725,578 shares, as a passive investor on Sep 30, 2026. Filed Oct 30, 2026 (Schedule 13G).

Stake
5.04%
Shares
5,725,578
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
Vanguard Capital Management5.04%5,725,578

Source

Download original · View original at SEC

Related